Sterling Capital Management’s Bright Minds Biosciences DRUG Stock Holding History

Sterling Capital Management’s Portfolio DRUG Stock Details DRUG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.82K	Sell	26 -19	-42%	-$1.49K	﹤0.01%	3012
2026 Q1	$3.28K	Buy	45 +15	+50%	+$1.21K	﹤0.01%	2867
2025 Q4	$2.34K	Buy	30 +19	+173%	+$1.27K	﹤0.01%	3047
2025 Q3	$667	Hold	11	–	–	﹤0.01%	3135
2025 Q2	$287	Buy	+11	New	+$330	﹤0.01%	3211

Other funds holding DRUG

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

SIC

SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

Sterling Capital Management's DRUG Position: Q2 2026 in Review

Sterling Capital Management reduced its Bright Minds Biosciences (DRUG) stake by 42% in Q2 2026, selling an estimated $1.49K and leaving 26 shares worth $1.82K. The position accounts for ﹤0.01% of the portfolio, ranked #3012.

Sterling Capital Management first reported a position in DRUG in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.28K in Q1 2026. 11 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

Sterling Capital Management held 26 shares of Bright Minds Biosciences worth $1.82K as of Q2 2026.
Sterling Capital Management sold 19 Bright Minds Biosciences shares in Q2 2026, an estimated $1.49K.
Bright Minds Biosciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3012 holding.
Sterling Capital Management first reported a position in Bright Minds Biosciences in Q2 2025 and has held it in 5 quarters since.
Sterling Capital Management's Bright Minds Biosciences position peaked at $3.28K in Q1 2026.
11 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.